Journal
NANOSCALE
Volume 2, Issue 10, Pages 1884-1891Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c0nr00173b
Keywords
-
Categories
Funding
- Nano-materials for Cancer Diagnostics and Therapeutics [5 U54CA119341-02]
- National Institutes of Health/NIBIB [1 R01EB005866-01]
- NATIONAL CANCER INSTITUTE [U54CA119341] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005866] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Magnetic resonance imaging (MRI) has become a powerful technique in biological molecular imaging and clinical diagnosis. With the rapid progress in nanoscale science and technology, nanostructure-based MR contrast agents are undergoing rapid development. This is in part due to the tuneable magnetic and cellular uptake properties, large surface area for conjugation and favourable biodistribution. In this review, we describe our recent progress in the development of high-performance nanostructured MR contrast agents. Specifically, we report on Gd-enriched nanostructured probes that exhibit T-1 MR contrast and superparamagnetic Fe3O4 and CoFe2O4 nanostructures that display T-2 MR contrast enhancement. The effects of nanostructure size, shape, assembly and surface modification on relaxivity are described. The potential of these contrast agents for in vitro and in vivo MR imaging with respect to colloidal stability under physiological conditions, biocompatibility, and surface functionality are also evaluated.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available